HEADER LIGASE/LIGASE INHIBITOR 24-JAN-15 4XTV TITLE MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE TITLE 2 INHIBITOR 36 (N-({[(1R,3S)-3-(6-AMINO-9H-PURIN-9-YL) TITLE 3 CYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS,4S,6AR)-2-OXOHEXAHYDRO-1H- TITLE 4 THIENO[3,4-D]IMIDAZOL-4-YL]PENTANAMIDE) CAVEAT 4XTV ENTRY CONTAINS ATOMS WITH OCCUPANCY GREATER THAN 1.00. COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL LIGASE/REPRESSOR BIRA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BIOTIN--ACETYL-COA-CARBOXYLASE LIGASE,BIOTIN-PROTEIN LIGASE, COMPND 5 BIRA PROTEIN; COMPND 6 EC: 6.3.4.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: BIRA, CH81_03124, CH82_03406, CH84_03412, CH85_03111, SOURCE 5 CH87_01691, CH88_02592, CO60_3782, ER17_17395, FF22_02902, SOURCE 6 FI98_01129, IQ38_01820, IQ39_01720, IQ40_01775, IQ41_01700, SOURCE 7 IQ42_01770, IQ43_01710, IQ44_01750, IQ45_01765, IQ46_01705, SOURCE 8 IQ47_01735, IQ48_01770, IU12_01860, IU13_01785, IU14_01730, SOURCE 9 IU16_01770, IU17_01745, IU18_01730, IU19_01775, IU20_01750, SOURCE 10 IU22_01755, IU23_01750, IU24_01735, IZ84_17515, JE53_17495, SOURCE 11 LJ70_17695, T209_01770; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: MACH I; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS BIOTIN-PROTEIN LIGASE, BISUBSTRATE INHIBITOR, LIGASE-LIGASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.DE LA MORA-REY,B.C.FINZEL REVDAT 5 27-SEP-23 4XTV 1 REMARK REVDAT 4 11-DEC-19 4XTV 1 REMARK REVDAT 3 06-SEP-17 4XTV 1 REMARK REVDAT 2 07-OCT-15 4XTV 1 JRNL REMARK REVDAT 1 02-SEP-15 4XTV 0 JRNL AUTH M.R.BOCKMAN,A.S.KALINDA,R.PETRELLI,T.DE LA MORA-REY, JRNL AUTH 2 D.TIWARI,F.LIU,S.DAWADI,M.NANDAKUMAR,K.Y.RHEE, JRNL AUTH 3 D.SCHNAPPINGER,B.C.FINZEL,C.C.ALDRICH JRNL TITL TARGETING MYCOBACTERIUM TUBERCULOSIS BIOTIN PROTEIN LIGASE JRNL TITL 2 (MTBPL) WITH NUCLEOSIDE-BASED BISUBSTRATE ADENYLATION JRNL TITL 3 INHIBITORS. JRNL REF J.MED.CHEM. V. 58 7349 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26299766 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00719 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.354 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 91060 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 4562 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.4269 - 4.5028 1.00 3115 159 0.1700 0.1811 REMARK 3 2 4.5028 - 3.5750 1.00 2976 158 0.1560 0.1716 REMARK 3 3 3.5750 - 3.1234 1.00 2913 172 0.1666 0.1930 REMARK 3 4 3.1234 - 2.8379 1.00 2919 169 0.1832 0.2039 REMARK 3 5 2.8379 - 2.6346 1.00 2901 147 0.1945 0.2015 REMARK 3 6 2.6346 - 2.4793 1.00 2900 160 0.1887 0.2230 REMARK 3 7 2.4793 - 2.3551 1.00 2885 151 0.1884 0.1945 REMARK 3 8 2.3551 - 2.2526 1.00 2908 146 0.1898 0.1940 REMARK 3 9 2.2526 - 2.1659 1.00 2863 157 0.1870 0.2162 REMARK 3 10 2.1659 - 2.0912 1.00 2916 135 0.1898 0.2189 REMARK 3 11 2.0912 - 2.0258 1.00 2865 168 0.1946 0.2066 REMARK 3 12 2.0258 - 1.9679 1.00 2851 152 0.1886 0.2124 REMARK 3 13 1.9679 - 1.9161 1.00 2852 154 0.1917 0.1995 REMARK 3 14 1.9161 - 1.8694 1.00 2876 168 0.1962 0.2115 REMARK 3 15 1.8694 - 1.8269 1.00 2857 164 0.2058 0.2492 REMARK 3 16 1.8269 - 1.7880 1.00 2855 153 0.2066 0.2199 REMARK 3 17 1.7880 - 1.7522 1.00 2875 137 0.2043 0.2285 REMARK 3 18 1.7522 - 1.7192 1.00 2870 152 0.2007 0.1989 REMARK 3 19 1.7192 - 1.6884 1.00 2852 138 0.2060 0.2453 REMARK 3 20 1.6884 - 1.6598 1.00 2883 155 0.2061 0.2695 REMARK 3 21 1.6598 - 1.6331 1.00 2829 158 0.2052 0.2445 REMARK 3 22 1.6331 - 1.6079 1.00 2895 142 0.2068 0.2000 REMARK 3 23 1.6079 - 1.5843 1.00 2840 152 0.2094 0.2410 REMARK 3 24 1.5843 - 1.5620 1.00 2853 139 0.2062 0.2446 REMARK 3 25 1.5620 - 1.5409 1.00 2863 145 0.2122 0.2180 REMARK 3 26 1.5409 - 1.5208 1.00 2850 154 0.2145 0.2442 REMARK 3 27 1.5208 - 1.5018 1.00 2870 130 0.2141 0.2561 REMARK 3 28 1.5018 - 1.4837 1.00 2869 145 0.2207 0.2525 REMARK 3 29 1.4837 - 1.4665 1.00 2854 138 0.2204 0.2582 REMARK 3 30 1.4665 - 1.4500 1.00 2843 164 0.2350 0.2745 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.134 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.292 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4202 REMARK 3 ANGLE : 0.976 5765 REMARK 3 CHIRALITY : 0.054 674 REMARK 3 PLANARITY : 0.004 767 REMARK 3 DIHEDRAL : 14.928 1603 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XTV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000206252. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 91151 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 36.415 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.34700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3RUX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17-24% PEG2000 MME, 100 MM TRIS, PH REMARK 280 8.5, 100 MM TRIETHYLAMINE N-OXIDE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.94800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.85650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.46850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.85650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.94800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.46850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 VAL A 1 REMARK 465 ARG A 266 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 VAL B 1 REMARK 465 THR B 2 REMARK 465 PRO B 121 REMARK 465 ALA B 122 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL B 119 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 130 21.68 -148.19 REMARK 500 ASN A 130 42.39 -158.67 REMARK 500 GLN A 148 131.95 -38.11 REMARK 500 VAL A 166 -46.60 -131.72 REMARK 500 ASP A 167 138.67 -172.85 REMARK 500 ALA B 23 -94.23 -125.57 REMARK 500 VAL B 166 -47.99 -130.30 REMARK 500 GLN B 207 31.15 -77.55 REMARK 500 GLN B 231 55.33 -101.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 751 DISTANCE = 5.89 ANGSTROMS REMARK 525 HOH A 752 DISTANCE = 6.27 ANGSTROMS REMARK 525 HOH A 753 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH A 754 DISTANCE = 6.93 ANGSTROMS REMARK 525 HOH A 755 DISTANCE = 7.69 ANGSTROMS REMARK 525 HOH B 682 DISTANCE = 6.16 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 44K A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 44K B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4XTU RELATED DB: PDB REMARK 900 RELATED ID: 4XTW RELATED DB: PDB REMARK 900 RELATED ID: 4XTX RELATED DB: PDB REMARK 900 RELATED ID: 4XTY RELATED DB: PDB REMARK 900 RELATED ID: 4XTZ RELATED DB: PDB REMARK 900 RELATED ID: 4XU0 RELATED DB: PDB REMARK 900 RELATED ID: 4XU1 RELATED DB: PDB REMARK 900 RELATED ID: 4XU2 RELATED DB: PDB REMARK 900 RELATED ID: 4XU3 RELATED DB: PDB DBREF1 4XTV A 2 266 UNP A0A045H8W3_MYCTX DBREF2 4XTV A A0A045H8W3 2 266 DBREF1 4XTV B 2 266 UNP A0A045H8W3_MYCTX DBREF2 4XTV B A0A045H8W3 2 266 SEQADV 4XTV GLY A -3 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV SER A -2 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV HIS A -1 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV MET A 0 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV VAL A 1 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV GLY B -3 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV SER B -2 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV HIS B -1 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV MET B 0 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTV VAL B 1 UNP A0A045H8W EXPRESSION TAG SEQRES 1 A 270 GLY SER HIS MET VAL THR ASP ARG ASP ARG LEU ARG PRO SEQRES 2 A 270 PRO LEU ASP GLU ARG SER LEU ARG ASP GLN LEU ILE GLY SEQRES 3 A 270 ALA GLY SER GLY TRP ARG GLN LEU ASP VAL VAL ALA GLN SEQRES 4 A 270 THR GLY SER THR ASN ALA ASP LEU LEU ALA ARG ALA ALA SEQRES 5 A 270 SER GLY ALA ASP ILE ASP GLY VAL VAL LEU ILE ALA GLU SEQRES 6 A 270 HIS GLN THR ALA GLY ARG GLY ARG HIS GLY ARG GLY TRP SEQRES 7 A 270 ALA ALA THR ALA ARG ALA GLN ILE ILE LEU SER VAL GLY SEQRES 8 A 270 VAL ARG VAL VAL ASP VAL PRO VAL GLN ALA TRP GLY TRP SEQRES 9 A 270 LEU SER LEU ALA ALA GLY LEU ALA VAL LEU ASP SER VAL SEQRES 10 A 270 ALA PRO LEU ILE ALA VAL PRO PRO ALA GLU THR GLY LEU SEQRES 11 A 270 LYS TRP PRO ASN ASP VAL LEU ALA ARG GLY GLY LYS LEU SEQRES 12 A 270 ALA GLY ILE LEU ALA GLU VAL ALA GLN PRO PHE VAL VAL SEQRES 13 A 270 LEU GLY VAL GLY LEU ASN VAL THR GLN ALA PRO GLU GLU SEQRES 14 A 270 VAL ASP PRO ASP ALA THR SER LEU LEU ASP LEU GLY VAL SEQRES 15 A 270 ALA ALA PRO ASP ARG ASN ARG ILE ALA SER ARG LEU LEU SEQRES 16 A 270 ARG GLU LEU GLU ALA ARG ILE ILE GLN TRP ARG ASN ALA SEQRES 17 A 270 ASN PRO GLN LEU ALA ALA ASP TYR ARG ALA ARG SER LEU SEQRES 18 A 270 THR ILE GLY SER ARG VAL ARG VAL GLU LEU PRO GLY GLY SEQRES 19 A 270 GLN ASP VAL VAL GLY ILE ALA ARG ASP ILE ASP ASP GLN SEQRES 20 A 270 GLY ARG LEU CYS LEU ASP VAL GLY GLY ARG THR VAL VAL SEQRES 21 A 270 VAL SER ALA GLY ASP VAL VAL HIS LEU ARG SEQRES 1 B 270 GLY SER HIS MET VAL THR ASP ARG ASP ARG LEU ARG PRO SEQRES 2 B 270 PRO LEU ASP GLU ARG SER LEU ARG ASP GLN LEU ILE GLY SEQRES 3 B 270 ALA GLY SER GLY TRP ARG GLN LEU ASP VAL VAL ALA GLN SEQRES 4 B 270 THR GLY SER THR ASN ALA ASP LEU LEU ALA ARG ALA ALA SEQRES 5 B 270 SER GLY ALA ASP ILE ASP GLY VAL VAL LEU ILE ALA GLU SEQRES 6 B 270 HIS GLN THR ALA GLY ARG GLY ARG HIS GLY ARG GLY TRP SEQRES 7 B 270 ALA ALA THR ALA ARG ALA GLN ILE ILE LEU SER VAL GLY SEQRES 8 B 270 VAL ARG VAL VAL ASP VAL PRO VAL GLN ALA TRP GLY TRP SEQRES 9 B 270 LEU SER LEU ALA ALA GLY LEU ALA VAL LEU ASP SER VAL SEQRES 10 B 270 ALA PRO LEU ILE ALA VAL PRO PRO ALA GLU THR GLY LEU SEQRES 11 B 270 LYS TRP PRO ASN ASP VAL LEU ALA ARG GLY GLY LYS LEU SEQRES 12 B 270 ALA GLY ILE LEU ALA GLU VAL ALA GLN PRO PHE VAL VAL SEQRES 13 B 270 LEU GLY VAL GLY LEU ASN VAL THR GLN ALA PRO GLU GLU SEQRES 14 B 270 VAL ASP PRO ASP ALA THR SER LEU LEU ASP LEU GLY VAL SEQRES 15 B 270 ALA ALA PRO ASP ARG ASN ARG ILE ALA SER ARG LEU LEU SEQRES 16 B 270 ARG GLU LEU GLU ALA ARG ILE ILE GLN TRP ARG ASN ALA SEQRES 17 B 270 ASN PRO GLN LEU ALA ALA ASP TYR ARG ALA ARG SER LEU SEQRES 18 B 270 THR ILE GLY SER ARG VAL ARG VAL GLU LEU PRO GLY GLY SEQRES 19 B 270 GLN ASP VAL VAL GLY ILE ALA ARG ASP ILE ASP ASP GLN SEQRES 20 B 270 GLY ARG LEU CYS LEU ASP VAL GLY GLY ARG THR VAL VAL SEQRES 21 B 270 VAL SER ALA GLY ASP VAL VAL HIS LEU ARG HET 44K A 301 36 HET 44K B 301 36 HETNAM 44K N-({[(1R,3S)-3-(6-AMINO-9H-PURIN-9-YL) HETNAM 2 44K CYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS,4S,6AR)-2- HETNAM 3 44K OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANAMIDE FORMUL 3 44K 2(C21 H31 N9 O4 S2) FORMUL 5 HOH *637(H2 O) HELIX 1 AA1 THR A 2 ARG A 8 5 7 HELIX 2 AA2 ASP A 12 ILE A 21 1 10 HELIX 3 AA3 SER A 38 SER A 49 1 12 HELIX 4 AA4 ARG A 69 GLY A 71 5 3 HELIX 5 AA5 PRO A 94 ALA A 97 5 4 HELIX 6 AA6 TRP A 98 ALA A 114 1 17 HELIX 7 AA7 PRO A 115 ILE A 117 5 3 HELIX 8 AA8 ALA A 162 ASP A 167 1 6 HELIX 9 AA9 LEU A 173 GLY A 177 5 5 HELIX 10 AB1 ASP A 182 ASN A 203 1 22 HELIX 11 AB2 ASN A 205 ARG A 215 1 11 HELIX 12 AB3 ARG B 4 ARG B 8 5 5 HELIX 13 AB4 ASP B 12 ILE B 21 1 10 HELIX 14 AB5 SER B 38 SER B 49 1 12 HELIX 15 AB6 ARG B 69 GLY B 71 5 3 HELIX 16 AB7 PRO B 94 GLY B 99 5 6 HELIX 17 AB8 TRP B 100 ALA B 114 1 15 HELIX 18 AB9 ALA B 162 ASP B 167 1 6 HELIX 19 AC1 ASP B 182 ASN B 203 1 22 HELIX 20 AC2 PRO B 206 ARG B 215 1 10 HELIX 21 AC3 LEU B 227 GLN B 231 5 5 SHEET 1 AA1 7 GLN A 29 THR A 36 0 SHEET 2 AA1 7 VAL A 56 GLN A 63 1 O VAL A 57 N GLN A 29 SHEET 3 AA1 7 GLN A 81 ARG A 89 -1 O ILE A 83 N ALA A 60 SHEET 4 AA1 7 PHE A 150 ASN A 158 -1 O VAL A 155 N LEU A 84 SHEET 5 AA1 7 GLY A 137 ALA A 147 -1 N ALA A 147 O PHE A 150 SHEET 6 AA1 7 ASP A 131 ALA A 134 -1 N VAL A 132 O LEU A 139 SHEET 7 AA1 7 GLY A 125 LYS A 127 -1 N GLY A 125 O LEU A 133 SHEET 1 AA2 2 GLY A 66 ARG A 67 0 SHEET 2 AA2 2 GLY A 73 TRP A 74 -1 O TRP A 74 N GLY A 66 SHEET 1 AA310 ASP A 261 HIS A 264 0 SHEET 2 AA310 ARG A 222 GLU A 226 -1 N GLU A 226 O ASP A 261 SHEET 3 AA310 ASP A 232 ILE A 240 -1 O GLY A 235 N VAL A 223 SHEET 4 AA310 LEU A 246 VAL A 250 -1 O CYS A 247 N ASP A 239 SHEET 5 AA310 ARG A 253 VAL A 257 -1 O ARG A 253 N VAL A 250 SHEET 6 AA310 ARG B 253 VAL B 257 -1 O VAL B 256 N VAL A 256 SHEET 7 AA310 LEU B 246 VAL B 250 -1 N LEU B 248 O VAL B 255 SHEET 8 AA310 VAL B 233 ILE B 240 -1 N ASP B 239 O CYS B 247 SHEET 9 AA310 ARG B 222 GLU B 226 -1 N VAL B 223 O GLY B 235 SHEET 10 AA310 ASP B 261 HIS B 264 -1 O ASP B 261 N GLU B 226 SHEET 1 AA4 7 GLN B 29 THR B 36 0 SHEET 2 AA4 7 VAL B 56 GLN B 63 1 O ILE B 59 N VAL B 33 SHEET 3 AA4 7 GLN B 81 ARG B 89 -1 O ILE B 83 N ALA B 60 SHEET 4 AA4 7 PHE B 150 ASN B 158 -1 O VAL B 155 N LEU B 84 SHEET 5 AA4 7 GLY B 137 ALA B 147 -1 N GLU B 145 O VAL B 152 SHEET 6 AA4 7 ASP B 131 ALA B 134 -1 N VAL B 132 O LEU B 139 SHEET 7 AA4 7 GLY B 125 LYS B 127 -1 N GLY B 125 O LEU B 133 SHEET 1 AA5 2 GLY B 66 ARG B 67 0 SHEET 2 AA5 2 GLY B 73 TRP B 74 -1 O TRP B 74 N GLY B 66 CISPEP 1 TRP A 128 PRO A 129 0 3.05 CISPEP 2 GLN A 148 PRO A 149 0 7.36 CISPEP 3 TRP B 128 PRO B 129 0 1.48 CISPEP 4 GLN B 148 PRO B 149 0 8.64 SITE 1 AC1 26 SER A 38 THR A 39 ASN A 40 GLN A 63 SITE 2 AC1 26 GLY A 66 ARG A 67 GLY A 68 ARG A 69 SITE 3 AC1 26 ARG A 72 GLY A 73 TRP A 74 ALA A 75 SITE 4 AC1 26 GLN A 81 ILE A 83 ASN A 130 LYS A 138 SITE 5 AC1 26 GLY A 141 ILE A 142 LEU A 143 VAL A 155 SITE 6 AC1 26 GLY A 156 ASN A 158 VAL A 166 ASP A 167 SITE 7 AC1 26 ALA A 170 HOH A 470 SITE 1 AC2 27 SER B 38 THR B 39 ASN B 40 GLN B 63 SITE 2 AC2 27 GLY B 66 ARG B 67 GLY B 68 ARG B 69 SITE 3 AC2 27 ARG B 72 GLY B 73 TRP B 74 ALA B 75 SITE 4 AC2 27 GLN B 81 ILE B 83 ASN B 130 LYS B 138 SITE 5 AC2 27 GLY B 141 ILE B 142 VAL B 155 GLY B 156 SITE 6 AC2 27 ASN B 158 VAL B 166 ASP B 167 ALA B 170 SITE 7 AC2 27 HOH B 433 HOH B 498 HOH B 557 CRYST1 63.896 68.937 115.713 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015650 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014506 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008642 0.00000